1.2K
Recently, Prometheus Biosciences went public and raised $190M in its IPO. The company develops precision antibody therapies for IBD and related diseases. Read more here.
Prometheus Biosciences Raises $190M
previous post
Recently, Prometheus Biosciences went public and raised $190M in its IPO. The company develops precision antibody therapies for IBD and related diseases. Read more here.
Stay up to date on the latest insights into San Diego's tech community! Highlighting local leaders, connecting the great community and being your "one-stop" for all things technology.